Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-055341
Filing Date
2021-09-09
Accepted
2021-09-09 17:34:24
Documents
1
Period of Report
2021-09-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4068
  Complete submission text file 0001209191-21-055341.txt   5430
Mailing Address C/O XENOPORT, INC. 3410 CENTRAL EXPRESSWAY SANTA CLARA CA 95051
Business Address
Barrett Ronald W (Reporting) CIK: 0001326330 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40475 | Film No.: 211245294

Mailing Address 11099 TORREY PINES PARK ROAD SAN DIEGO CA 92037
Business Address 11099 TORREY PINES PARK ROAD SAN DIEGO CA 92037 858-750-4700
Janux Therapeutics, Inc. (Issuer) CIK: 0001817713 (see all company filings)

EIN.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations